CLINICAL EVALUATION OF A RECOMBINANT HEPATITIS B VACCINE
- 1 November 1984
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 324 (8413) , 1174-1175
- https://doi.org/10.1016/s0140-6736(84)92740-5
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Persistenz von Antikörpern gegen Hepatitis-B-Oberflächenantigen nach Impfung gegen Hepatitis BDeutsche Medizinische Wochenschrift (1946), 1985
- Human hepatitis B vaccine from recombinant yeastNature, 1984
- Hepatitis B surface antigen (HBsAg) subtype‐specific antibodies in persons vaccinated against hepatitis BJournal of Medical Virology, 1984
- Synthesis and assembly of hepatitis B virus surface antigen particles in yeastNature, 1982
- A controlled clinical trial of the efficacy of the hepatitis B vaccine (heptavax B): A final reportHepatology, 1981
- RANDOMISED PLACEBO-CONTROLLED TRIAL OF HEPATITIS B SURFACE ANTIGEN VACCINE IN FRENCH HAEMODIALYSIS UNITS: I, MEDICAL STAFFThe Lancet, 1981
- Nucleotide sequence of the gene coding for the major protein of hepatitis B virus surface antigenNature, 1979